Lupin Secures US FDA Approval for Rivaroxaban, Production Set for Aurangabad

Unknown Apr 02, 2026 2,200 Views

Lupin Limited has received approval from the US Food and Drug Administration for its Rivaroxaban tablets, marking a significant milestone in the company’s expansion into the anticoagulant market. The tablets will be manufactured at Lupin’s Aurangabad facility in India, reinforcing the...